2014, Number 6
<< Back Next >>
Ann Hepatol 2014; 13 (6)
MELD exception for liver transplantation in portopulmonary hypertension: current implementation and future considerations
Porres-Aguilar M, Bartolome SD, Duarte-Rojo A
Language: English
References: 7
Page: 719-721
PDF size: 63.59 Kb.
Text Extraction
Portopulmonary hypertension (PoPH) is a serious
lung vascular complication of portal hypertension.
Current definition criteria for PoPH include
the following:
• Presence of portal hypertension with or without
cirrhosis.
• Presence of pulmonary arterial hypertension
(PAH) diagnosed by right heart catheterization
(RHC); and absence of an alternative cause for
PAH. Hemodynamic criteria for PAH, as based
on RHC, must include a mean pulmonary arterial
pressure (mPAP) ≥ 25 mmHg at rest, and pulmonary
vascular resistance (PVR) › 240 dynes/
sec/cm
-5 [PVR = mPAP - PAOP/cardiac output
(CO) x 80] or › 3 Wood units (Wood units=
mPAP – PAOP/CO).
1,2 Ideally, pulmonary arterial
occlusion pressure (PAOP) should be ≤ 15
mmHg, and whenever this criterion is not met,
the transpulmonary gradient (TPG) must be ›
12 mmHg, reflecting the presence of true PAH in
association with venous hypertension.
REFERENCES
Rodriguez-Roisin R, Krowka MJ, Herve P, Fallon MB. Pulmonary- hepatic vascular disorders. Eur Respir J 2004; 24: 860-80.
Porres-Aguilar M, Altamirano JT, Torre-Delgadillo A, Charlton MR, Duarte-Rojo A. Portopulmonary hypertension and hepatopulmonary syndrome: a clinician-oriented overview. Eur Respir Rev 2012; 21: 223-33.
Krowka MJ, Miller DP, Barst RJ, Taichman D, Dweik RA, Badesch DB, McGoon MD. Portopulmonary hypertension: a report from the US-based REVEAL registry. Chest 2012; 141: 906-15.
Krowka MJ, Mandell MS, Ramsay MA, Kawut SM, Fallon MB, Manzarbeitia C, Pardo M Jr, et al. Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant. Liver Transpl 2004; 10: 174-82.
Krowka MJ, Fallon MB, Mulligan DC, Gish RG. Model of endstage liver disease (MELD) exception for portopulmonary hypertension. Liver Transpl 2006; 12: S114-S116.
Goldberg DS, Batra S, Sahay S, Kawut SM, Fallon MB. MELD exceptions for portopulmonary hypertension: Current policy and future implementation. Am J Transplant 2014. Doi: 10.1111/ajt.12783 [Epub ahead of print].
Porres-Aguilar M, Mukherjee D. Cardiopulmonary hemodynamics for accurate diagnosis of portopulmonary hypertension: A redefinition to consider. Hepatology 2014. Doi: 10.1002/hep.27234 [Epub ahead of print].